Related Experiment Video
Updated: Jul 18, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Substrate recognition and catalysis by UCH-L1
Sarah J Luchansky1, Peter T Lansbury, Ross L Stein
1Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital and Laboratory for Drug Discovery in Neurodegeneration, Harvard Center for Neurodegeneration and Repair, Cambridge, Massachusetts 02139, USA. sarah.luchansky@gmail.com
Abstract:
Deubiquitinating enzymes regulate essential cellular processes, and their dysregulation is implicated in multiple disease states. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) has garnered attention for its links with Parkinson's disease and cancer; however, the mechanism of action of this enzyme in cells remains poorly understood. In order to advance our understanding of UCH-L1 function, we have been developing small molecule modulators of the enzyme for use as tools to probe its role in cells. In support of these efforts, an investigation of the mechanism of UCH-L1 catalysis was previously reported. Here, we extend this mechanistic evaluation and examine substrate recognition by UCH-L1. We developed a panel of ubiquitin fusions to test the contribution of specific residues of ubiquitin to binding and catalysis by the enzyme, and determined the activation parameters of selected variants to gain additional mechanistic insight. Ubiquitin side chains critical for establishing the Michaelis complex and enabling catalysis were identified, and features of this complex that differ between UCH-L1 and a homologue, UCH-L3, were revealed. These data provide dramatic examples of differences in substrate specificity between these enzymes. The implications of our experiments with UCH-L1 for selective inhibitor design and the relationship to disease are discussed.
Insights
Researchers explored how Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) recognizes its ubiquitin substrate. Key ubiquitin residues were identified, revealing differences between UCH-L1 and UCH-L3 enzyme specificity for potential disease-targeted drug design.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- Deubiquitinating enzymes are crucial for cellular processes, with their malfunction linked to diseases.
- Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is associated with Parkinson's disease and cancer, but its cellular function is unclear.
- Small molecule modulators are being developed to study UCH-L1's cellular roles.
Purpose of the Study:
- To investigate the substrate recognition mechanism of UCH-L1.
- To identify specific ubiquitin residues involved in UCH-L1 binding and catalysis.
- To compare the substrate specificity of UCH-L1 with its homologue, UCH-L3.
Main Methods:
- Development of a panel of ubiquitin fusion proteins to probe enzyme-substrate interactions.
- Determination of activation parameters for selected ubiquitin variants.
- Comparative analysis of UCH-L1 and UCH-L3 binding and catalytic mechanisms.
Main Results:
- Identification of critical ubiquitin side chains essential for forming the Michaelis complex and catalysis.
- Elucidation of distinct substrate recognition features between UCH-L1 and UCH-L3.
- Demonstration of significant differences in substrate specificity between the two enzymes.
Conclusions:
- Specific ubiquitin residues are vital for UCH-L1's enzymatic activity.
- UCH-L1 and UCH-L3 exhibit differential substrate specificities, offering opportunities for selective inhibitor design.
- Understanding these mechanistic differences can inform therapeutic strategies for UCH-L1-associated diseases.
More Related Videos
09:47Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Ligand Binding and Linkage
Introduction to Mechanisms of Enzyme Catalysis
Introduction to Mechanisms of Enzyme Catalysis
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...